English
Français
Deutsch
Italiano
Português
Español
Kiswahili
Yorùbá
Zulu
Harshen Hausa
This article is an on-site version of our Unhedged newsletter. Premium subscribers can sign up here to get the newsletter delivered every weekday. Standard subscribers can upgrade to Premium here, or explore all FT newsletters
Good morning. Stocks, especially tech stocks, had an ugly morning yesterday but rallied in the afternoon. Biotech stocks, particularly Moderna, Charles River Labs and other vaccine makers, were hit hardest, after a top Food and Drug Administration vaccine official
Read the full article here
